Acute Administration of the GLP-1 Receptor Agonist Lixisenatide Diminishes Postprandial Insulin Secretion in Healthy Subjects But Not in Type 2 Diabetes, Associated with Slowing of Gastric Emptying

INTRODUCTION: It is uncertain whether lixisenatide has postprandial insulinotropic effects when its effect on slowing gastric emptying is considered, in healthy subjects and type 2 diabetes mellitus (T2DM). We evaluated the effects of single administration of 10 μg sc lixisenatide on glycaemia, insu...

Descripción completa

Detalles Bibliográficos
Autores principales: Marathe, Chinmay S., Pham, Hung, Wu, Tongzhi, Trahair, Laurence G., Rigda, Rachael S., Buttfield, Madeline D. M., Hatzinikolas, Seva, Lange, Kylie, Rayner, Christopher K., Mari, Andrea, Horowitz, Michael, Jones, Karen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174387/
https://www.ncbi.nlm.nih.gov/pubmed/35460043
http://dx.doi.org/10.1007/s13300-022-01258-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174387/
https://www.ncbi.nlm.nih.gov/pubmed/35460043
http://dx.doi.org/10.1007/s13300-022-01258-4

Ejemplares similares